 |
 |
 |
 |
 |
 |
 |
 |
 |  | Engineering targeted therapeutics
|  | Private
|  | 2007
|
 |
 |  | Develops novel small molecule drugs for unmet medical needs
|  | Private
|  | 2006
|
 |
 |  | Breakthrough invention to synthesize tetracycline compounds for use in antibiotics
|  | Private
|  | 2006
|
 |
 |  | Developing new treatments for celiac sprue
|  | Private
|  | 2006
|
 |
 |  | Discovery and development of therapeutics for inflammatory diseases
|  | Private
|  | 2006
|
 |
 |  | Discovery, development and commercialization of targeted therapeutics to treat cancer and other diseases
|  | Private
|  | 2005
|
 |
 |  | Develops real-time tools to monitor thermal ablation of tumors
|  | Private
|  | 2005
|
 |
 |  | Using proprietary technology developing drugs to treat musculoskeletal and metabolic disorders
|  | Private
|  | 2004
|
 |
 |  | Developing a revolutionary approach to control chemical synthesis, enabling discovery of chemical compounds and reactions on an unprecedented scale
|  | Private
|  | 2004
|
 |
 |  | Creates biologically active vascular interventions to treat significant unmet needs in cardiovascular disease
|  | Private
|  | 2003
|
 |
 |  | Product-focused biopharmaceutical company positioned to revolutionize cancer drug discovery and development [fka GenPath Pharmaceuticals]
|  | Private
|  | 2003
|
 |
 |  | CombinatoRx is creating new combination medicines that attack disease on multiple fronts
|  | Private
|  | 2002
|
 |
 |  | Develops novel kinase inhibitors for the treatment of cancer and autoimmune and inflammatory diseases [fka Cellular Gemomics]
|  | Private
|  | 2001
|
 |